AI Prediction Only Drugs
TxGNN model predictions without clinical evidence - research hypotheses for exploration
Evidence Standards
| Level | Definition | Clinical Significance |
|---|---|---|
| L5 | AI prediction only, no clinical evidence | Research hypothesis, requires validation |
Caution: L5 predictions are based on knowledge graph analysis only. They should NOT be used for clinical decision-making and require rigorous validation before any therapeutic application.
Drug List
L5 Level (588 drugs)
| Drug Name | Indications | Link |
|---|---|---|
| Abacavir | 50 | View Report |
| Abaloparatide | 50 | View Report |
| Abatacept | 50 | View Report |
| Abemaciclib | 50 | View Report |
| Abiraterone Acetate | 50 | View Report |
| Acalabrutinib | 50 | View Report |
| Acetylsalicylic Acid | 54 | View Report |
| Aclidinium Bromide | 50 | View Report |
| Adalimumab | 61 | View Report |
| Afamelanotide | 50 | View Report |
| Afatinib | 50 | View Report |
| Aflibercept | 54 | View Report |
| Agalsidase Beta | 50 | View Report |
| Albutrepenonacog Alfa | 50 | View Report |
| Alectinib Hydrochloride | 50 | View Report |
| Alemtuzumab | 50 | View Report |
| Alendronic Acid | 50 | View Report |
| Alglucosidase Alfa | 50 | View Report |
| Alirocumab | 52 | View Report |
| Alogliptin | 51 | View Report |
| Alpelisib | 50 | View Report |
| Ambrisentan | 50 | View Report |
| Amifampridine Phosphate | 50 | View Report |
| Amikacin Sulfate | 50 | View Report |
| Amlodipine | 50 | View Report |
| Anagrelide | 50 | View Report |
| Anakinra | 52 | View Report |
| Andexanet Alfa | 50 | View Report |
| Angiotensin Ii Acetate | 50 | View Report |
| Anidulafungin | 51 | View Report |
| Anifrolumab | 50 | View Report |
| Apalutamide | 51 | View Report |
| Apixaban | 50 | View Report |
| Apremilast | 51 | View Report |
| Aprepitant | 50 | View Report |
| Aripiprazole | 50 | View Report |
| Arsenic Trioxide | 52 | View Report |
| Artenimol | 50 | View Report |
| Artesunate | 50 | View Report |
| Asenapine Maleate | 50 | View Report |
| Asfotase Alfa | 50 | View Report |
| Atosiban (As Acetate) | 50 | View Report |
| Atropine Sulfate | 50 | View Report |
| Avanafil | 52 | View Report |
| Avapritinib | 51 | View Report |
| Avatrombopag Maleate | 50 | View Report |
| Avelumab | 50 | View Report |
| Axicabtagene Ciloleucel | 50 | View Report |
| Axitinib | 50 | View Report |
| Azacitidine | 51 | View Report |
| Azilsartan Medoxomil | 50 | View Report |
| Aztreonam | 52 | View Report |
| Baloxavir Marboxil | 50 | View Report |
| Baricitinib | 50 | View Report |
| Basiliximab | 50 | View Report |
| Bazedoxifene | 50 | View Report |
| Bedaquiline Fumarate | 50 | View Report |
| Belatacept | 50 | View Report |
| Belimumab | 52 | View Report |
| Bempedoic Acid | 50 | View Report |
| Benralizumab | 52 | View Report |
| Besilesomab | 50 | View Report |
| Bevacizumab | 70 | View Report |
| Bexarotene | 50 | View Report |
| Bezlotoxumab | 50 | View Report |
| Bictegravir | 50 | View Report |
| Bimekizumab | 50 | View Report |
| Binimetinib | 50 | View Report |
| Blinatumomab | 50 | View Report |
| Bortezomib | 50 | View Report |
| Bosentan (As Monohydrate) | 50 | View Report |
| Bosutinib (As Monohydrate) | 50 | View Report |
| Botulinum Toxin Type A | 50 | View Report |
| Brentuximab Vedotin | 51 | View Report |
| Brexpiprazole | 50 | View Report |
| Brigatinib | 51 | View Report |
| Brimonidine Tartrate | 50 | View Report |
| Brinzolamide | 50 | View Report |
| Brivaracetam | 50 | View Report |
| Brodalumab | 50 | View Report |
| Brolucizumab | 50 | View Report |
| Budesonide | 52 | View Report |
| Bupivacaine | 50 | View Report |
| Buprenorphine | 50 | View Report |
| Burosumab | 51 | View Report |
| Busulfan | 50 | View Report |
| Cabazitaxel | 50 | View Report |
| Cabotegravir | 50 | View Report |
| Cabozantinib | 50 | View Report |
| Caffeine Citrate | 50 | View Report |
| Canagliflozin | 50 | View Report |
| Canakinumab | 56 | View Report |
| Cangrelor | 50 | View Report |
| Cannabidiol | 53 | View Report |
| Capecitabine | 51 | View Report |
| Capsaicin | 51 | View Report |
| Carbidopa | 50 | View Report |
| Carfilzomib | 50 | View Report |
| Carglumic Acid | 50 | View Report |
| Cariprazine Hydrochloride | 50 | View Report |
Showing first 100 of 588 drugs. See Full Drug List for all.
Statistics
| Metric | Value |
|---|---|
| Total L5 Drugs | 588 |
| Total Predictions | 32,368 |
| Unique Indications | 4,570 |
Validation Pathway
To upgrade from L5 to higher evidence levels:
L5 (AI Prediction)
↓ Literature search
L4 (Preclinical/Mechanistic)
↓ Observational studies
L3 (Cohort/Case-control)
↓ Phase 2 trials
L2 (Single RCT)
↓ Multiple Phase 3 trials
L1 (Strong Evidence)
Download L5 Data
All L5 predictions available at: